
Adani Group posts record EBITDA of Rs 90,000 cr in FY25
Adani Group's portfolio companies posted their highest-ever pre-tax profit (EBITDA) of about Rs 90,000 crore in the fiscal year ended March 31 and had a cash balance to cover 21 months of debt servicing, the ports-to-energy conglomerate said on Thursday.
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Adani Group's portfolio companies posted their highest-ever pre-tax profit ( EBITDA ) of about Rs 90,000 crore in the fiscal year ended March 31 and had a cash balance to cover 21 months of debt servicing, the ports-to-energy conglomerate said on Thursday. The Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) has more than tripled in six years - from Rs 24,870 crore in 2018-19 to Rs 89,806 crore in 2024-25 (April 2024 to March 2025).EBITDA grew by 8.2 per cent from Rs 82,976 crore in FY24 to Rs 89,806 crore in FY25, with a 6-year (FY19-FY25) Compounded Annual Growth Rate (CAGR) of 24 per cent.Net profit for 2024-25 came in at Rs 40,565 crore and has seen a six-year CAGR of 48.5 per cent.Gross Assets have increased to Rs 609,133 lakh crore, with a 6-year CAGR of over 25 per cent, the conglomerate said in a press statement.The group, which is on a massive spending spree from airports to renewable energy parks, saw gross debt climb to Rs 2.9 lakh crore from Rs 2.41 crore in FY24. After considering Rs 53,843 crore of cash balance, the net debt was Rs 2.36 lakh crore in FY25.The group said that cash balances provide liquidity cover for 21 million of debt servicing obligations."ROA in FY25 reached 16.5 per cent, one of the highest amongst infrastructure players globally," it said. "Prudent capital allocation has led to steady Return on Asset (ROA) at 16 per cent, showcasing no compromise on ROA to achieve high growth."The accelerated profit growth has reduced leverage - net debt-to-EBITDA is down from 3.8x in FY19 to 2.6x in FY25. Cash balance of Rs 53,843 cr represents 18.5 per cent of gross debt."A key highlight of FY25 is the continued industry-beating Return on Assets of 16.5 per cent, which is amongst the highest in any infrastructure business globally, underpinning the attractive asset base and the execution capabilities of the Adani Portfolio to continuously churn out the best quality assets across sub sectors," said Jugeshinder 'Robbie' Singh, Group CFO, Adani Group."Additionally, we have undertaken various initiatives related to governance and ESG, viz., tax transparency report released by all portfolio companies, in addition to all the other initiatives introduced over the past years, resulting in industry-best ESG scores and performance by international ESG rating agencies."Adani Group said 82 per cent of the EBITDA is contributed by the highly stable 'core infrastructure' platform, lending a high level of stability and visibility.Adani's 'core infrastructure' platform comprises utility (Adani Green Energy, Adani Power, Adani Energy Solutions, and Adani Total Gas), transport (Adani Ports and SEZ), and Adani Enterprise Ltd's incubating infrastructure businesses.Cash after tax (CAT) or fund flow from operations (FFO) increased to Rs 66,527 crore, up 13.6 per cent, driven by strong operating leverage across businesses.Higher cashflows helped record asset addition of Rs 1.26 lakh crore - the highest in the history of Adani Portfolio, taking the total gross assets to Rs 6.1 lakh crore. Three-fourths of this was added in the past six years.Prudent capital allocation, complemented by strong execution, has helped Adani Portfolio consistently achieve industry-leading Return on Asset of over 15 per cent in each of the past six years, it said adding ROA for FY25 was 16.5 per cent -- one of the highest globally in the infrastructure sector."High growth in profits has led to a sharp reduction in the leverage of portfolio companies - portfolio-level net debt to EBITDA has reduced from 3.8x in FY19 to as low as 2.6x now," the statement said.Robust financial performance across businesses has resulted in consistent ratings improvement with milestone achievement in FY25. Nearly 90 per cent of EBITDA is now generated from assets with domestic ratings of 'AA-' and above, as compared to 63 per cent and 48 per cent two and six years ago, respectively.As a result, the cost of debt for FY25 was 7.9 per cent against 9 per cent in FY24 and 10.3 per cent in FY19."In line with our conservative credit policies, sufficient liquidity is maintained across portfolio companies to cover debt servicing requirements for at least the next 12 months. As on March 31, 2025, Adani Portfolio had a cash balance of Rs 53,843 crore, representing 18.5 per cent of gross debt and is sufficient to cover 21 months of debt servicing requirements comfortably above our stated 12 months+1 day of debt servicing policy," it added.On operational performance, the group said solar module sale increased 59 per cent year-on-year to 4,263 MW while the passenger movement at Adani Airports rose by 7 per cent to 94.4 million.Operational green capacity increased by 30 per cent Y-o-Y to 14,243 MW with the addition of 2,710 MW solar and 599 MW wind power plants.The transmission line order book increased 3.5 times to Rs 59,936 crore, and Adani Energy Solutions won seven new transmission projects during FY25.Volumes handed by Adani Ports increased 7 per cent to 450 million tonnes, driven by strong growth in the container volume, up 20 per cent.Vizhinjam port, its newest, crossed the 100,000 TEUs (Twenty-foot Equivalent Unit) milestone in March 2025, just four months after becoming operational.The cement business has now crossed 100 million tonnes capacity - an increase of 21 million tonnes since FY24 end.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


India Gazette
38 minutes ago
- India Gazette
Rural FMCG volume grew thrice urban volume growth in Q4FY25, similar trend likely to continue: Report
New Delhi [India], June 30 (ANI): Driven by increased distribution of freebies and a positive sentiment from good monsoon, rural market in India's fast-moving consumer goods (FMCG) sector continues to outperform urban areas, according to a recent report by Nuvama Institutional Equities. The report stated that rural markets continued to outpace urban areas in the overall FMCG sector. It noted that rural demand is already doing well and remains strong, while urban markets are facing pressure and are likely to stay under strain until the first half of FY26. However, urban demand is expected to start improving from the second half of FY26, the report stated. In terms of volume growth, rural regions have shown remarkable performance. For the fourth consecutive quarter, rural areas have grown more than twice as fast as urban regions. In Q4FY25, rural FMCG volumes grew by 8.4 per cent, while urban volume growth stood at 2.6 per cent, it said. The report also highlighted that the FMCG sector volumes in Q4FY25 saw rural growth being three times higher than urban areas. Initial data for Q1FY26 suggests a similar trend is likely to continue. Overall, the consumer sector grew 11 per cent year-on-year (YoY) by value in Q4FY25, compared to 10.6 per cent YoY in Q3FY25. Pricing growth was reported at 5.6 per cent, while overall volumes expanded by 5.1 per cent YoY, a slight decline from the 7.1 per cent YoY growth recorded in Q3FY25. Despite the positive performance in rural markets, the FMCG sector saw a significant selloff by foreign portfolio investors (FPIs) in the first half of June 2025. According to the report, FMCG recorded the highest outflows of Rs 36.3 billion, after receiving net inflows worth Rs 8.2 billion in May. Until May, the sector witnessed sales worth over Rs 140 billion. The report added that FPIs showed a strong inclination towards rate-sensitive and beta plays, contributing to the withdrawal from FMCG stocks. (ANI)


News18
40 minutes ago
- News18
UP's Much-Awaited Pharma Park All Set To Become A Reality By 2027
Last Updated: With construction underway on over 350 acres in the first phase, the project is expected to catalyse investments worth over Rs 12,000 crore Uttar Pradesh's much-awaited Pharma Park is all set to become a reality by 2027 as the state government begins work on North India's first bulk drug and formulation hub in Lalitpur. With construction underway on over 350 acres in the first phase, the project is expected to catalyse investments worth over Rs 12,000 crore and boost UP's bid to become a national pharmaceutical manufacturing powerhouse. Spearheaded by the Uttar Pradesh State Industrial Development Authority (UPSIDA), the Lalitpur Bulk Drug Pharma Park is part of UP government's move to make the state self-reliant in bulk drug and Active Pharmaceutical Ingredient (API) production, while transforming Bundelkhand into an industrial powerhouse. Spread over 1,472 acres, the park is being developed in phases. Construction work for the first phase, covering 353 acres, is already underway. According to UPSIDA, environmental clearances have been secured, and land allotment to industries has begun. UPSIDA regional manager Sandeep Kumar confirmed that four pharmaceutical companies have submitted applications to set up units within the park. Of these, IJ Pharma and Badariya Pharma have already been allotted plots, while Riddhi Siddhi Pharma and JBJM Pharmaceuticals are in the final stages of the allotment process. 'Contracts with two companies are complete, while documentation for the remaining two is ongoing," Kumar said. The project has already caught the attention of prominent investors. During a recent investment roadshow in Ahmedabad, several pharma companies signed key proposals. UPSIDA CEO Mayur Maheshwari stated that the authority will conduct similar outreach initiatives in Mumbai, Chandigarh, and Hyderabad to attract more pharma players. Maheshwari described the park as a 'state-of-the-art plug-and-play facility" tailored to meet global standards. 'All utilities—electricity, water, waste management—are being designed for 24/7 industrial support. The entire park will be based on Zero Liquid Discharge (ZLD), ensuring that no untreated wastewater leaves the premises," he said. The park's underground utility network will include steam and solvent recovery systems, climate-controlled warehouses, and dedicated logistics corridors. A waste management system with a 3.53 TPD capacity, 33/11 KV sub-stations, and a 75 TPH steam distribution system will be in place to ensure operational efficiency. Safety and support infrastructure are also in focus. Plans include CCTV surveillance, boundary fencing, emergency service centers, and in-house skilling centres for local manpower training. Affordable housing for workers and executives is also under development within the premises. Investor Incentives UPSIDA has rolled out a special industrial land allotment scheme for the pharma park. Plots are priced at Rs 1,914 per square meter, with an additional 2 per cent discount for one-time payment. These rates, according to UPSIDA officials, are highly competitive compared to other pharma hubs in India and are expected to attract significant interest from small and mid-sized pharmaceutical players. 'Infrastructure, regulatory clearances, and affordability are all aligned to offer investors a compelling alternative to Gujarat or Hyderabad," said Maheshwari. The Lalitpur Pharma Park has already begun attracting significant industrial investments. CSL Life Sciences Pvt Ltd has proposed a Rs 200 crore investment to set up two manufacturing units—an IV Bottle Plant and an Oral Solid Dosage (OSD) Plant—spread over 5 to 7 acres. These units are expected to generate employment for over 250 people and become operational within the next two years. In addition, Mediheath Diagnostic Pvt Ltd is establishing a healthcare and diagnostic unit on a 4,200-square-meter plot, while Gaman Irradiation has announced plans to invest Rs 35 crore in a skin treatment and irradiation facility that is projected to create around 150 jobs within 24 to 36 months. Another major entrant, Obmed Pharma, has committed Rs 200 crore for setting up a formulation unit on a five-acre plot, which is expected to employ approximately 100 workers. These early investments signal strong industry confidence in the project and are expected to accelerate momentum as the park gains visibility on the national pharmaceutical landscape. Strong Connectivity The Lalitpur pharma park benefits from excellent multi-modal connectivity. The site is linked via MDR 35B, with NH-44 and NH-539 nearby, and is connected by rail through Tikamgarh and Lalitpur Junction. Air connectivity is facilitated via Khajuraho Airport (125 km away) and Lucknow Airport (385 km away). The proximity to the Jhansi node of the Uttar Pradesh Defence Corridor adds strategic value, as does its alignment with the state's broader goal of becoming a $1 trillion economy. According to Maheshwari, the Lalitpur pharma park is being developed in collaboration with leading national institutions like IIT, DRDO, and private consultancy firm Assystem India Limited, which has experience working on world-class pharma parks in Visakhapatnam. top videos View all 'We're not just matching global standards — we're aiming to surpass them," he said. 'Uttar Pradesh is well-positioned to fill the gap left after tax benefits in Himachal Pradesh ended. With the right policies, infrastructure, and investor confidence, we're ready to take the lead in pharma manufacturing." With construction in full swing, the park is expected to show physical results within two years, potentially transforming Lalitpur into India's premier bulk drug manufacturing hub. First Published: News india UP's Much-Awaited Pharma Park All Set To Become A Reality By 2027


Economic Times
40 minutes ago
- Economic Times
Market Wrap: Sensex drops 452 pts, dragged by financial stocks; Nifty slips below 25,550
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel India's benchmark indices, Sensex and Nifty, ended lower on Monday, the final trading day of the first half of CY25, as profit booking in financial stocks near record highs outweighed gains from improved global risk sentiment. Easing Middle East tensions and a sharp rebound in foreign inflows had bolstered investor confidence, but failed to offset the drag from domestic BSE Sensex declined 452.44 points, or 0.54%, to close at 83,606.46, while the NSE Nifty shed 120.75 points, or 0.47%, to settle at 25, market capitalisation of all listed companies on the BSE shrank by Rs 2,396.6 crore to Rs 461.10 lakh Nifty and Sensex closed about 2.9% and 2.8% below their record highs hit in September, after advancing 2.7% over the past four sessions. For June, the indices gained 3.1% and 2.7%, respectively, marking a fourth straight monthly in financial stocks near record levels offset optimism from easing geopolitical tensions. The Nifty Financial Services index fell 0.6%, with heavyweight HDFC Bank slipping 0.7%.In contrast, broader markets outperformed. The Nifty Midcap 100 rose 0.6% and the Nifty Smallcap 100 added 0.5%. Sigachi Industries plunged 11.5% after a deadly explosion at its Hyderabad facility killed at least eight people and injured over two dozen, according to reports. Torrent Pharma gained 2% after announcing plans to acquire a 46.4% stake in JB Chemicals from private equity firm KKR. JB Chemicals, however, dropped 6.8% as the deal was priced at a discount to its last traded level. Alembic Pharma jumped 7.3% after receiving U.S. FDA approval for an injectable cancer treatment used in ovarian and other cancers.